LAURA KELSO: Open Payments
NPI 1356664262 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,333 in 38 payments from 14 companies in 2025. Trend: 2023 $1,552 · 2024 $1,574 · 2025 $3,333
Consulting: $2,495Food & beverage: $690Education: $148
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 2 | $2,511 |
| Fresenius USA Marketing, Inc. | 7 | $158 |
| OPKO Pharmaceuticals, LLC | 8 | $148 |
| Abbott Laboratories | 2 | $137 |
| Vifor Pharma, Inc. | 3 | $72 |
| Travere Therapeutics, Inc. | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Amgen Inc. | 2 | $31 |
Products named: TARPEYO, VELPHORO, RAYALDEE, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, Veltassa, JYNARQUE, Fabhalta, FARXIGA.
Industry payments across KY — which companies pay providers there.
